Slideshow
Here’s a brief look at medications for rheumatologic disorders that were approved or granted a new indication in 2018.
Meta-Analysis Confirms Efficacy of Small Molecules for Psoriatic Arthritis
Emerging Agents in the Treatment of Rheumatic Diseases
DMARD-Free Remission Feasible for bDMARD-Naive Patients for RA
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
Rheumatology Month in Review: December 2024
Gabapentin Does Not Increase Risk of Falls in Older Adults with Fibromyalgia